Skip to main content
. 2017 May;9(5):1295–1302. doi: 10.21037/jtd.2017.03.167

Figure 1.

Figure 1

Overall survival curves by all patients or each clinicopathological factors. (A) Overall survival of pulmonary pleomorphic carcinoma (n=24); (B) overall survival of pulmonary pleomorphic carcinoma divided by the vascular invasion (P=0.042); (C) overall survival of pulmonary pleomorphic carcinoma divided by the lymph node metastasis (P=0.000493).